• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆中恶唑磷氮芥类细胞抑制药物代谢物氯乙醛的测定。

Determination of chloroacetaldehyde, a metabolite of oxazaphosphorine cytostatic drugs, in plasma.

作者信息

Kaijser G P, Beijnen J H, Jeunink E L, Bult A, Keizer H J, de Kraker J, Underberg W J

机构信息

Department of Pharmaceutical Analysis, Faculty of Pharmacy, Utrecht University, Netherlands.

出版信息

J Chromatogr. 1993 May 5;614(2):253-9. doi: 10.1016/0378-4347(93)80316-v.

DOI:10.1016/0378-4347(93)80316-v
PMID:8314937
Abstract

A derivatization high-performance liquid chromatographic method with ultraviolet detection to monitor the plasma concentration of chloroacetaldehyde, a neurotoxic metabolite of oxazaphosphorine drugs, is presented. To prevent the rapid degradation of chloroacetaldehyde, the plasma samples are stabilized with formaldehyde. The method is linear in the concentration range 1-250 nmol/ml. Blood samples from a patient who was treated with a ten-day continuous infusion of ifosfamide were assayed. The chloroacetaldehyde concentrations did not exceed 10 nmol/ml.

摘要

本文介绍了一种采用紫外检测的衍生化高效液相色谱法,用于监测氮杂磷类药物的神经毒性代谢物氯乙醛的血浆浓度。为防止氯乙醛快速降解,血浆样品用甲醛进行稳定处理。该方法在1-250 nmol/ml的浓度范围内呈线性。对一名接受了十天异环磷酰胺持续输注治疗的患者的血样进行了检测。氯乙醛浓度未超过10 nmol/ml。

相似文献

1
Determination of chloroacetaldehyde, a metabolite of oxazaphosphorine cytostatic drugs, in plasma.血浆中恶唑磷氮芥类细胞抑制药物代谢物氯乙醛的测定。
J Chromatogr. 1993 May 5;614(2):253-9. doi: 10.1016/0378-4347(93)80316-v.
2
Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapy.分次静脉注射异环磷酰胺治疗患者中异环磷酰胺、4-羟基异环磷酰胺、氯乙醛以及2-和3-去氯乙基异环磷酰胺的比较药代动力学
Cancer Chemother Pharmacol. 1993;33(1):36-42. doi: 10.1007/BF00686020.
3
High-performance liquid chromatographic-fluorescent method to determine chloroacetaldehyde, a neurotoxic metabolite of the anticancer drug ifosfamide, in plasma and in liver microsomal incubations.
Anal Biochem. 1999 Aug 15;273(1):117-25. doi: 10.1006/abio.1999.4197.
4
Renal-tubule metabolism of ifosfamide to the nephrotoxic chloroacetaldehyde: pharmacokinetic modeling for estimation of intracellular levels.异环磷酰胺在肾小管代谢为肾毒性氯乙醛:用于估算细胞内水平的药代动力学模型。
J Lab Clin Med. 2004 Mar;143(3):159-62. doi: 10.1016/j.lab.2003.10.013.
5
Metabolism and pharmacokinetics of oral and intravenous ifosfamide.口服和静脉注射异环磷酰胺的代谢及药代动力学
J Cancer Res Clin Oncol. 1991;117 Suppl 4(Suppl 4):S148-53. doi: 10.1007/BF01613221.
6
Comparative toxicity of ifosfamide metabolites and protective effect of mesna and amifostine in cultured renal tubule cells.异环磷酰胺代谢产物的比较毒性以及美司钠和氨磷汀对培养肾小管细胞的保护作用。
Toxicol In Vitro. 2003 Aug;17(4):397-402. doi: 10.1016/s0887-2333(03)00044-4.
7
Ifosfamide metabolite chloroacetaldehyde causes renal dysfunction in vivo.异环磷酰胺代谢产物氯乙醛在体内会导致肾功能障碍。
J Appl Toxicol. 1997 Jan-Feb;17(1):75-9. doi: 10.1002/(sici)1099-1263(199701)17:1<75::aid-jat397>3.0.co;2-c.
8
Toxicity of ifosfamide and its metabolite chloroacetaldehyde in cultured renal tubule cells.异环磷酰胺及其代谢产物氯乙醛对培养肾小管细胞的毒性作用。
In Vitro Cell Dev Biol Anim. 1999 Jun;35(6):314-7. doi: 10.1007/s11626-999-0080-y.
9
Metabolism of ifosfamide to chloroacetaldehyde contributes to antitumor activity in vivo.异环磷酰胺代谢生成氯乙醛有助于其在体内的抗肿瘤活性。
Drug Metab Dispos. 2000 May;28(5):573-6.
10
Evidence of renal metabolism of ifosfamide to nephrotoxic metabolites.异环磷酰胺在肾脏代谢为肾毒性代谢物的证据。
Life Sci. 2000 Nov 24;68(1):109-17. doi: 10.1016/s0024-3205(00)00915-2.

引用本文的文献

1
CITCO as an Adjuvant Facilitates CHOP-Based Lymphoma Treatment in hCAR-Transgenic Mice.CITCO 作为一种佐剂促进了 hCAR 转基因小鼠基于 CHOP 的淋巴瘤治疗。
Cells. 2020 Nov 21;9(11):2520. doi: 10.3390/cells9112520.
2
Oxazaphosphorine bioactivation and detoxification The role of xenobiotic receptors.氧氮磷杂环生物活化与解毒:外源性物质受体的作用
Acta Pharm Sin B. 2012 Apr 1;2(2). doi: 10.1016/j.apsb.2012.02.004.
3
The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies.
组成型雄烷受体是一种新的治疗靶点,有助于基于环磷酰胺的血液系统恶性肿瘤的治疗。
Blood. 2013 Jan 10;121(2):329-38. doi: 10.1182/blood-2012-06-436691. Epub 2012 Nov 16.
4
Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus.系统性红斑狼疮患者谷胱甘肽S-转移酶基因型与脉冲环磷酰胺治疗副作用的关系
Br J Clin Pharmacol. 2006 Oct;62(4):457-72. doi: 10.1111/j.1365-2125.2006.02690.x.
5
Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites.异环磷酰胺及其代谢产物的临床药代动力学和药效学
Clin Pharmacokinet. 2001 Jan;40(1):41-62. doi: 10.2165/00003088-200140010-00004.
6
Ifosfamide clinical pharmacokinetics.异环磷酰胺的临床药代动力学。
Clin Pharmacokinet. 1994 Jun;26(6):439-56. doi: 10.2165/00003088-199426060-00003.